Compumedics (ASX:CMP) has announced it has made progress towards its goal of up to tripling sales in its key target markets.
The company, which develops and commercialises computre-based patient monitoring and diagnostic systems, received an order worth $760,000 from its distributor to North China, Bestmed Tech.
The order, covering the company's latest sleep and EEG diagnostic equipment, represents a year-on-year growth of 33%, Compumedics said in a market update.
Bestmed has been a Compumedics distributor for 10 years, and the relationship has so far generated over $5 million in business from China.
The company views China as a unique emerging market opportunity, given its size and proximity to Australia, the update stated.
Compumedics is headquartered in Melbourne ands has offices in the US and Europe. It claims a distribution network coving some 50 countries.
CMP shares stayed flat in Monday's trading at $0.095.
Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.